Sunday’s Midday Movers: Intercept Pharma (ICPT), TG Therapeutics (TGTX), Apache (APA), Clovis Oncology (CLVS), BP Prudhoe Bay (BPT)

By Carrie Williams

So far Sunday, December 8, NASDAQ is up 1.17% and the S&P is up 0.75%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Intercept Pharma (ICPTResearch Report), TG Therapeutics (TGTXResearch Report), Apache (APAResearch Report), Clovis Oncology (CLVSResearch Report) and BP Prudhoe Bay (BPTResearch Report).

Intercept Pharma is down -10.43% in midday trading to $107.48. Shares opened today at $120.00. The company has a 52-week low of $56.76 and a 52-week high of $131.87. On the Street’s front, the average 12-month analyst price target for the stock is $158.80, marking a 32.33% potential upside from current levels. In a report issued on December 2, Canaccord Genuity analyst Edward Nash initiated coverage with a Buy rating on ICPT and a price target of $165.00, which represents a potential upside of 38% from where the stock is currently trading. Separately, on November 25, Stifel Nicolaus’ Derek Archila maintained a Hold rating on the stock and has a price target of $102.00. In the last 30 days, insiders have sold $176.6K worth of ICPT shares and purchased $4,370 worth of ICPT shares.

TG Therapeutics is down -8.48% in midday trading to $7.12. Shares opened today at $7.78. The company has a 52-week low of $3.32 and a 52-week high of $9.38. On the Street’s front, the average 12-month analyst price target for the stock is $16.00, marking a 105.66% potential upside from current levels. In a report issued on November 27, B.Riley FBR analyst Mayank Mamtani initiated coverage with a Buy rating on TGTX and a price target of $12.00, which implies an upside of 54% from current levels.

Apache is up 8.05% in midday trading to $19.99. Shares opened today at $18.50. The company has a 52-week low of $18.33 and a 52-week high of $38.12. On the Street’s front, the average 12-month analyst price target for the stock is $23.95, marking a 29.46% potential upside from current levels. In a report issued on December 6, Barclays analyst Jeanine Wai maintained a Sell rating on APA, with a price target of $22.00, which implies an upside of 19% from current levels. Separately, on the same day, Credit Suisse’s William Featherston maintained a Hold rating on the stock and has a price target of $16.00.

See today’s analyst top recommended stocks >>

Clovis Oncology is up 7.98% in midday trading to $9.61. Shares opened today at $8.90. The company has a 52-week low of $2.93 and a 52-week high of $32.05. On the Street’s front, the average 12-month analyst price target for the stock is $11.42, marking a 28.31% potential upside from current levels. In a report issued on November 19, Evercore ISI analyst Joshua Schimmer downgraded CLVS to Hold, with a price target of $8.00, which represents a potential downside of 10% from where the stock is currently trading. Separately, on November 8, H.C. Wainwright’s Edward White reiterated a Buy rating on the stock and has a price target of $36.00. In the last 30 days, insiders purchased $34.55K worth of CLVS shares.

See today’s analyst top recommended stocks >>

BP Prudhoe Bay is up 7.55% in midday trading to $6.84. Shares opened today at $6.36. The company has a 52-week low of $5.60 and a 52-week high of $28.27.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.